Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival

Ana Slipicevic(Norwegian Cancer Society), Viví Ann Flørenes(Oslo University Hospital), Gunhild M. Mælandsmo(Oslo University Hospital), Danny R. Welch(The University of Kansas Cancer Center), Anne Katrine Ree Rosnes(Norwegian Cancer Society), Ruth Holm(University of Aleppo), Elisabeth Emilsen(Norwegian Cancer Society)
BMC Cancer
January 1, 2012
Cited by 1


Related Papers